20:11 EDT Cathie Wood’s ARK Investment buys 124K shares of Recursion Pharmaceuticals today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals’ Groundbreaking Cancer Drug Enters Clinical Trials
- Recursion receives FDA clearance for Phase 1/2 clinical trial of REC-1245
- Cathie Wood’s ARK Investment bought 726.5K shares of Recursion Pharmaceuticals
- Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals
- ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz